February 18, 2022
Genetic-screening company Natera Inc. knowingly sold and marketed unreliable prenatal tests to doctors and pregnant women that incorrectly indicated healthy fetuses had serious birth defects, sometimes leading to abortions, according to a proposed class action filed in California federal court Thursday.